VOYA Investment Management’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,370
Closed -$20K 2778
2022
Q1
$20K Hold
1,370
﹤0.01% 2647
2021
Q4
$72K Sell
1,370
-71
-5% -$3.95K ﹤0.01% 2711
2021
Q3
$84K Hold
1,441
﹤0.01% 2773
2021
Q2
$116K Hold
1,441
﹤0.01% 2746
2021
Q1
$120K Buy
1,441
+121
+9% +$12.3K ﹤0.01% 2644
2020
Q4
$100K Buy
1,320
+264
+25% +$23.6K ﹤0.01% 2562
2020
Q3
$113K Hold
1,056
﹤0.01% 2319
2020
Q2
$160K Sell
1,056
-333
-24% -$32.8K ﹤0.01% 2230
2020
Q1
$116K Hold
1,389
﹤0.01% 2306
2019
Q4
$235K Buy
1,389
+239
+21% +$39.4K ﹤0.01% 2296
2019
Q3
$213K Hold
1,150
﹤0.01% 2220
2019
Q2
$263K Buy
1,150
+74
+7% +$14.5K ﹤0.01% 2141
2019
Q1
$226K Hold
1,076
﹤0.01% 2209
2018
Q4
$124K Hold
1,076
﹤0.01% 2355
2018
Q3
$247K Hold
1,076
﹤0.01% 2241
2018
Q2
$240K Sell
1,076
-83
-7% -$18.6K ﹤0.01% 2278
2018
Q1
$265K Hold
1,159
﹤0.01% 2173
2017
Q4
$304K Sell
1,159
-60
-5% -$14.1K ﹤0.01% 2129
2017
Q3
$274K Hold
1,219
﹤0.01% 2214
2017
Q2
$333K Buy
1,219
+148
+14% +$40.1K ﹤0.01% 2085
2017
Q1
$259K Hold
1,071
﹤0.01% 2134
2016
Q4
$222K Hold
1,071
﹤0.01% 2230
2016
Q3
$292 Hold
1,071
﹤0.01% 2054
2016
Q2
$154K Buy
+1,071
New +$144K ﹤0.01% 2365
2015
Q3
Sell
-1,223
Closed -$316K 2574
2015
Q2
$316K Hold
1,223
﹤0.01% 2226
2015
Q1
$275K Hold
1,223
﹤0.01% 2282
2014
Q4
$235K Hold
1,223
﹤0.01% 2398
2014
Q3
$263K Hold
1,223
﹤0.01% 2352
2014
Q2
$318K Buy
+1,223
New +$267K ﹤0.01% 2306

Other funds holding AXDX

VOYA Investment Management's AXDX Position: Q2 2022 in Review

VOYA Investment Management sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 1,370 shares — an estimated $20K sold.

VOYA Investment Management first reported a position in AXDX in Q2 2014 and held it in 29 quarters. The position peaked at $333K in Q2 2017. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • VOYA Investment Management reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 1,370 Accelerate Diagnostics shares in Q2 2022, an estimated $20K.
  • VOYA Investment Management first reported a position in Accelerate Diagnostics in Q2 2014 and held it in 29 quarters.
  • VOYA Investment Management's Accelerate Diagnostics position peaked at $333K in Q2 2017.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.